<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Seetharama D Jois | PlatCOVID</title>
    <link>/author/seetharama-d-jois/</link>
      <atom:link href="/author/seetharama-d-jois/index.xml" rel="self" type="application/rss+xml" />
    <description>Seetharama D Jois</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>BioHub - UFPE</copyright><lastBuildDate>Mon, 18 May 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu7e12209333f22d741aca7d462871821f_9877_512x512_fill_lanczos_center_2.png</url>
      <title>Seetharama D Jois</title>
      <link>/author/seetharama-d-jois/</link>
    </image>
    
    <item>
      <title>The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.</title>
      <link>/publication/32374457/</link>
      <pubDate>Mon, 18 May 2020 00:00:00 +0000</pubDate>
      <guid>/publication/32374457/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
